Dr. Prasad Devarajan, M.D.
Pediatric Nephrology (Pediatric Nephrology Physician)
At a glance
- Years since graduation
- 43
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Nephrology Physician primary
OH license 35.082097
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cincinnati Children's Hospital Medical Center Cincinnati, OH
Medical groups
- Children's Hospital Medical Center (711 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 9 companies reported 75 payments worth $75,247 in total to this clinician.
| Novo Nordisk Inc | $72,992 |
|---|---|
| Beckman Coulter, Inc. | $1,000 |
| Tanabe Pharma America, Inc. | $575 |
| Travere Therapeutics, Inc. | $229 |
| Sentynl Therapeutics, Inc. | $150 |
| Amgen Inc. | $140 |
| Alnylam Pharmaceuticals Inc. | $103 |
| Vertex Pharmaceuticals Incorporated | $35.00 |
| Compensation for services other than consulting (speaking, faculty) | $51,874 |
|---|---|
| Travel and Lodging | $16,044 |
| Consulting Fee | $5,438 |
| Food and Beverage | $1,892 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novo Nordisk Inc Jul 29, 2025 | Compensation for services other than consulting (speaking, faculty) Rivfloza · Rare Disease | $5,288 |
| Novo Nordisk Inc May 3, 2025 | Compensation for services other than consulting (speaking, faculty) Rivfloza · Rare Disease | $4,838 |
| Novo Nordisk Inc Jun 5, 2025 | Compensation for services other than consulting (speaking, faculty) Rivfloza · Rare Disease | $4,838 |
| Novo Nordisk Inc Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) Rivfloza · Rare Disease | $4,838 |
| Novo Nordisk Inc Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,388 |
| Novo Nordisk Inc Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,388 |
| Novo Nordisk Inc Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,163 |
| Novo Nordisk Inc May 21, 2025 | Compensation for services other than consulting (speaking, faculty) Rivfloza · Rare Disease | $3,938 |
| Novo Nordisk Inc May 29, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,938 |
| Novo Nordisk Inc Jan 22, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,938 |
All 51 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Sentynl Therapeutics, Inc. Nov 5, 2025 | Consulting Fee | $150 |
| Beckman Coulter, Inc. Nov 3, 2025 | Consulting Fee AU · Devices | $1,000 |
| Novo Nordisk Inc Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) Rivfloza · Rare Disease | $2,925 |
| Novo Nordisk Inc Oct 8, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,388 |
| Novo Nordisk Inc Oct 8, 2025 | Travel and Lodging travel to Greenwood Village, CO · in-kind | $1,133 |
| Novo Nordisk Inc Oct 8, 2025 | Travel and Lodging travel to Greenwood Village, CO · in-kind | $777 |
| Novo Nordisk Inc Oct 8, 2025 | Travel and Lodging travel to Greenwood Village, CO · in-kind | $277 |
| Tanabe Pharma America, Inc. Sep 18, 2025 | Consulting Fee | $575 |
| Novo Nordisk Inc Jul 29, 2025 | Compensation for services other than consulting (speaking, faculty) Rivfloza · Rare Disease | $5,288 |
| Novo Nordisk Inc Jul 29, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Houston, TX · in-kind | $894 |
| Novo Nordisk Inc Jul 29, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Houston, TX · in-kind | $364 |
| Novo Nordisk Inc Jul 29, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Houston, TX · in-kind | $301 |
| Novo Nordisk Inc Jun 27, 2025 | Compensation for services other than consulting (speaking, faculty) Rivfloza · Rare Disease | $1,800 |
| Novo Nordisk Inc Jun 5, 2025 | Compensation for services other than consulting (speaking, faculty) Rivfloza · Rare Disease | $4,838 |
| Novo Nordisk Inc Jun 5, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Harrisburg, PA · in-kind | $1,315 |
| Novo Nordisk Inc Jun 5, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Harrisburg, PA · in-kind | $297 |
| Novo Nordisk Inc Jun 5, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Harrisburg, PA · in-kind | $221 |
| Novo Nordisk Inc May 29, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,938 |
| Novo Nordisk Inc May 29, 2025 | Travel and Lodging travel to King of Prussia, PA · in-kind | $731 |
| Novo Nordisk Inc May 29, 2025 | Travel and Lodging travel to King of Prussia, PA · in-kind | $684 |
| Novo Nordisk Inc May 29, 2025 | Travel and Lodging travel to King of Prussia, PA · in-kind | $313 |
| Novo Nordisk Inc May 21, 2025 | Compensation for services other than consulting (speaking, faculty) Rivfloza · Rare Disease | $3,938 |
| Novo Nordisk Inc May 21, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Raleigh, NC · in-kind | $613 |
| Novo Nordisk Inc May 21, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Raleigh, NC · in-kind | $225 |
| Novo Nordisk Inc May 21, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Raleigh, NC · in-kind | $221 |
| Novo Nordisk Inc May 3, 2025 | Compensation for services other than consulting (speaking, faculty) Rivfloza · Rare Disease | $4,838 |
| Novo Nordisk Inc May 3, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Portland, OR · in-kind | $869 |
| Novo Nordisk Inc May 3, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Portland, OR · in-kind | $294 |
| Novo Nordisk Inc May 3, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Portland, OR · in-kind | $232 |
| Novo Nordisk Inc Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) Rivfloza · Rare Disease | $4,838 |
| Novo Nordisk Inc Apr 14, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Beverly Hills, CA · in-kind | $807 |
| Novo Nordisk Inc Apr 14, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Beverly Hills, CA · in-kind | $271 |
| Novo Nordisk Inc Apr 14, 2025 | Travel and Lodging Rivfloza · Rare Disease · travel to Beverly Hills, CA · in-kind | $270 |
| Novo Nordisk Inc Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,163 |
| Novo Nordisk Inc Apr 10, 2025 | Travel and Lodging travel to New Orleans, LA · in-kind | $492 |
| Novo Nordisk Inc Apr 10, 2025 | Travel and Lodging travel to New Orleans, LA · in-kind | $335 |
| Novo Nordisk Inc Apr 10, 2025 | Travel and Lodging travel to New Orleans, LA · in-kind | $223 |
| Novo Nordisk Inc Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) Rivfloza · Rare Disease | $2,025 |
| Novo Nordisk Inc Mar 21, 2025 | Consulting Fee | $3,713 |
| Novo Nordisk Inc Mar 21, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $729 |
| Novo Nordisk Inc Mar 21, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $650 |
| Novo Nordisk Inc Mar 21, 2025 | Travel and Lodging travel to Miami, FL · in-kind | $629 |
| Novo Nordisk Inc Feb 27, 2025 | Compensation for services other than consulting (speaking, faculty) | $4,388 |
| Novo Nordisk Inc Feb 27, 2025 | Travel and Lodging travel to Denver, CO · in-kind | $882 |
| Novo Nordisk Inc Feb 27, 2025 | Travel and Lodging travel to Denver, CO · in-kind | $225 |
| Novo Nordisk Inc Feb 27, 2025 | Travel and Lodging travel to Denver, CO · in-kind | $202 |
| Novo Nordisk Inc Jan 22, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,938 |
| Novo Nordisk Inc Jan 22, 2025 | Travel and Lodging travel to McLean, VA · in-kind | $342 |
| Novo Nordisk Inc Jan 22, 2025 | Travel and Lodging travel to McLean, VA · in-kind | $187 |
| Novo Nordisk Inc Jan 22, 2025 | Travel and Lodging travel to McLean, VA · in-kind | $40.31 |
| Novo Nordisk Inc Jan 1, 2025 | Compensation for services other than consulting (speaking, faculty) | $574 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $9,230 in research payments for these studies, mostly to the institutions running them.
- BONAPHIDE: A prospective observational study of patients with primary hyperoxaluria type 1 (PHI).
Alnylam Pharmaceuticals Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.